Inventisbio Co., Ltd
Clinical trials sponsored by Inventisbio Co., Ltd, explained in plain language.
-
New psoriasis pill shows promise in Mid-Stage trial
Disease control CompletedThis study tested an experimental drug called D-2570 in 161 adults with moderate-to-severe plaque psoriasis. Participants received either the drug or a placebo for 12 weeks. The main goal was to see if the drug could clear at least 75% of skin plaques. This is a disease-control s…
Phase: PHASE2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Healthy volunteers needed for first human tests of new drug D-2570
Knowledge-focused CompletedThis early-stage study tested the safety of a new drug called D-2570 in 100 healthy adults aged 18 to 45. Participants received either the drug or a placebo, and researchers measured how the drug moved through the body and checked for side effects. The goal was to gather safety i…
Phase: PHASE1 • Sponsor: InventisBio Co., Ltd • Aim: Knowledge-focused
Last updated May 17, 2026 04:42 UTC